|
N
|
84
|
47
|
37
| |
|
Sex, female (%)
|
73 (86.90)
|
40 (85.11)
|
33 (89.19)
|
0.415
|
|
Age, years
|
31.88 ± 10.01
|
29.64 ± 8.78
|
34.73 ± 10.86
|
0.023
|
|
Disease duration, months
|
47.49 ± 66.03
|
34.96 ± 5.10
|
84.34 ± 13.87
|
0.001
|
|
Clinical manifestations
|
|
Hypertension (%)
|
20 (23.81)
|
7 (14.89)
|
13 (35.14)
|
0.029
|
|
Asymmetrical blood pressure (%)
|
3 (3.57)
|
3 (6.38)
|
0
|
0.170
|
|
Pulseless (%)
|
6 (7.14)
|
6 (12.77)
|
0
|
0.032
|
|
Fatigue (%)
|
7 (8.33)
|
7 (14.89)
|
0
|
0.016
|
|
Dizziness (%)
|
9 (10.71)
|
8 (17.02)
|
1 (2.70)
|
0.035
|
|
Neck pain (%)
|
14 (16.67)
|
14 (29.79)
|
0
|
< 0.001
|
|
Fever (%)
|
3 (3.57)
|
3 (6.38)
|
0
|
0.170
|
|
Received therapies (%)
|
49 (58.33)
|
20 (42.55)
|
29 (78.38)
|
0.001
|
|
Laboratory examination
|
|
ESR, mm/H
|
37.46 ± 32.95
|
50.72 ± 34.55
|
20.53 ± 21.25
|
< 0.001
|
|
CRP, mg/L
|
27.13 ± 44.19
|
41.37 ± 53.85
|
8.53 ± 11.66
|
0.001
|
|
SAA, mg/L
|
99.71 ± 176.38
|
144.01 ± 212.72
|
32.29 ± 52.87
|
0.017
|
|
Platelet count, ×109/L
|
301.23 ± 110.81
|
327.85 ± 123.58
|
267.22 ± 81.64
|
0.013
|
|
Kerr scores
|
1.89 ± 1.05
|
2.40 ± 0.92
|
1.24 ± 0.83
|
< 0.001
|
|
ITAS 2010 scores
|
3.43 ± 4.73
|
4.68 ± 4.93
|
1.84 ± 3.98
|
0.004
|
|
Ultrasound index
|
|
Carotid artery wall thickness, mm
|
2.12 ± 0.77
|
2.36 ± 0.86
|
1.79 ± 0.49
|
0.001
|
|
Carotid artery diameter, mm
|
3.73 ± 2.19
|
3.91 ± 1.92
|
3.48 ± 2.51
|
0.424
|
|
Diffuse lesions (%)
|
72 (85.71)
|
40 (85.11)
|
32 (86.49)
|
0.557
|
|
Proportions of vascular stenosis (%)
|
59 (70.24)
|
29 (61.70)
|
30 (81.08)
|
0.044
|
|
Proportions of vascular occlusion (%)
|
10 (11.90)
|
2 (4.26)
|
8 (21.62)
|
0.019
|
|
Carotid artery peak flow rate, m/s
|
1.37 ± 0.99
|
1.59 ± 1.04
|
1.08 ± 0.85
|
0.019
|
|
Carotid RI
|
0.73 ± 0.13
|
0.73 ± 0.13
|
0.72 ± 0.13
|
0.915
|
|
CEUS carotid wall vascularization grade 2 (%)
|
38 (45.24)
|
29 (61.70)
|
9 (24.32)
|
0.001
|
